Mediator of fever is?
**Core Concept:**
The core concept behind this question is understanding the mediators involved in the body's response to infection or injury, specifically focusing on fever. Fever is a physiological response to inflammation, infection, or tissue damage, aimed at enhancing the immune system's ability to combat pathogens.
**Why the Correct Answer is Right:**
The correct answer, **Option D: Prostaglandins**, is right because they are a group of lipid compounds that act as mediators in various physiological processes, including fever. Prostaglandins are synthesized from arachidonic acid, which is released from cell membranes upon inflammation or tissue damage. They are involved in the hypothalamic thermoregulation system, specifically affecting the thermoregulatory center.
**Why Each Wrong Option is Incorrect:**
A. **Option A: Interleukins (IL-1, IL-6)**: These are a group of proteins involved in inflammation and immune response, but they are not primarily responsible for fever. Interleukins primarily activate the hypothalamus to increase blood vessels' permeability and initiate shivering, while prostaglandins are the primary mediators of fever.
B. **Option B: Bradykinin**: Bradykinin is a substance involved in the inflammatory response but is not primarily responsible for fever. It is primarily involved in increasing vascular permeability and causing pain.
C. **Option C: Corticosteroids**: These are hormones produced by the adrenal glands that have anti-inflammatory properties. They have no direct role in the induction of fever.
**Clinical Pearl:**
Understanding the role of prostaglandins in fever helps in recognizing the importance of targeting prostaglandins in treating febrile conditions, such as in the use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, or aspirin. These drugs inhibit the synthesis of prostaglandins by blocking the cyclooxygenase (COX) enzymes, which reduces fever and alleviates pain and inflammation.
However, these drugs should be used cautiously in patients with bleeding disorders, renal disease, or heart disease, as they can increase the risk of bleeding, kidney damage, and heart failure, respectively.